ERBB2 and breast carcinoma: On the other hand, PAC1R-mediated EGFR activation may promote the proliferation of certain lung cancer cells by PKC-dependent EGFR activation [237], and VPAC1 signalling can transactivate EGFR and human epidermal growth factor receptor 2 (HER2) through PKA and Src signalling in breast cancer cells [238].